Lombard Medical Technologies Share Discussion Threads

[skinny] 15/2/2013 07:16

U.S. FDA Approval of Aorfix™

London, UK, 15 February 2013 - Lombard Medical Technologies PLC (AIM: LMT), the specialist medical technology company focused on innovative vascular products, today announces that Aorfix™ has been approved for commercial sale in the U.S. by the U.S. Food and Drug Administration ("FDA"). Aorfix™ is the Company's flexible stent graft for the endovascular repair of abdominal aortic aneurysms ("AAAs"). Data from the U.S. PYTHAGORAS trial of Aorfix™, has demonstrated that Aorfix™ can successfully treat a larger patient population than competing devices, including both standard and difficult to treat cases of AAAs.

[heyho2] 15/2/2013 07:08

Happy days!!! FDA Approval granted...

[rayrac] 14/2/2013 15:19

You are probably right. We shall see!

[shorewalk] 14/2/2013 10:49

Dropping this amount for so little volume feels a tree shake indicating something is going on. My bet is on news within the week. Hope for a little more of a drop so I can top up.

[heyho2] 14/2/2013 10:27

Looks like some of the short term crowd have got bored and moved on. An opportunity to top-up before the FDA Approval announcement.Just a waiting game now, but all good things come to he who waits... eventually!

[nobbygnome] 12/2/2013 11:16

The spread has got wider with no apparent trades. have the MMs got wind of something.....

Nobby

[shorewalk] 08/2/2013 11:12

Any sales being taken up without affecting share price £2 proving to be a resistance point, but I have a feeling news will come very soon.

[bmw30csl] 31/1/2013 15:46

that is a very good point and one i didnt think of at all
that makes 300p take out v conservative

[nobbygnome] 31/1/2013 08:40

So at the current market cap, a medical device company would almost get the products for free ;o)........

Seriously though that is an extremely good point and underpins the valuation considerably. They already have reasonable sales in the EU, which proves there is demand for the product so once the uncertainty of FDA approval is removed, then what is to stop a big company stepping in. Of course they would get the cash as well which currently would be north of £4 million. Somewhere around the £100 million mark would seem like a reasonable valuation in the short term.

Hmmmm I might have to get a few more.....

Nobby

[shorewalk] 31/1/2013 08:12

My understanding - and willing to be proved wrong by more knowledgable people- is that losses can be carried forward providing companies principle business doesn't change. So a company in the same field could buy it and use the losses, but not say an investment company or unrelated product just to use the tax losses.

[nod] 31/1/2013 07:35

shorewalk - interesting.
So, if the product sells well from here and the owner starts to make a profit each year, the owner can earn 79 million in future profits before paying a penny in tax. In simple terms is that how it works?

[shorewalk] 30/1/2013 20:25

Nod - the balance sheet at 1/2 yr showed accumulated losses of just shy of 79mill. Smart accountants can make use of most of it especially as UK Gov. has special rules for medical research companies.

[nod] 30/1/2013 10:15

shorewalk - very good point. does anyone know what the acc tax losses are? and are there any restrictions on an aquirer?

[shorewalk] 30/1/2013 07:26

From a valuation point of view one needs to take into account the accumulated tax losses that a purchaser could use making this a much cheaper aquisition target. The graph indicates £3 as an easy reach.

[nod] 30/1/2013 04:18

The market valuation is currently 38.6m - which doesn't seem high given the potential market. There are quite a few competitors in this specialised field. Perhaps one of those has access to cash to expand.

[bmw30csl] 30/1/2013 00:07

I think approval is fairly assured - FDA delays are the norm and am more interested in valuation thereafter. Quite easy to get to 300p on conservative market share and margin assumptions.

[rayrac] 29/1/2013 22:55

That's true, your next breath could go a begging. But then, most of us know that, same as we know every share is not a sure thing, even BP?

No point to your point multiplural?

[multiplural] 29/1/2013 22:25

I wonder what will happen if we don't get thet approval soon, if ever. Most investors here are in at this level simply because they think it is a sure thing. From my experience there is never a sure thing.

[rayrac] 29/1/2013 16:11

It's probably those watching and waiting for the FDA OK.

Thats what I'm here for. Must be due v soon.

[nobbygnome] 28/1/2013 19:04

I think the move today is very positive from a chart point of view. We have gone above the recent high and it looks like there is blue sky up to close to 2.5p.

In summary the chart looks really ecouraging!

Nobby

[shorewalk] 28/1/2013 10:19

Heyho2
Only a matter of time

[heyho2] 28/1/2013 10:18

Hello what's going on today! Sudden jump in share price Dies somebody know something? Are we finally going to get FDA approval?

[bmw30csl] 27/1/2013 00:43

At what price?

[nod] 24/1/2013 23:54

My money is on a takeout. Could happen any minute... :)